Biotech VC Funds

Newfund Capital, founded in 2008, is an entrepreneurial venture capital firm with a strong presence in both Paris and Silicon Valley. With $300 million in assets under management, Newfund focuses on seed-stage startups driving global change. Notable investments include Aircall, Fairmoney, and In2Bones, showcasing their diverse and impactful portfolio. The firm invests primarily in technology, precision medicine, personalized treatment, and brain tech sectors. They emphasize early-stage investments, aiming to support startups from the seed stage through international expansion, particularly in France and North America. Newfund's strategy involves quick decision-making, often providing term sheets within three weeks. They seek entrepreneurs with a global mindset and provide significant value beyond capital, including scaling opportunities, networking, and strategic support. The average check size varies but is tailored to meet the needs of each startup, with Newfund often leading the investment rounds. The team includes key members like Henri Deshays and Patrick Malka, who bring extensive entrepreneurial and investment experience. The team is split between their Paris and Palo Alto offices, allowing them to maintain a strong presence in both Europe and the U.S. For startups looking to scale rapidly with a partner who understands the entrepreneurial journey, Newfund Capital offers a compelling blend of expertise, resources, and strategic guidance.

Newpath Partners is a Boston-based venture capital firm specializing in life sciences. Founded in 2018 by Dr. Thomas Cahill, Newpath focuses on building biotechnology companies from the ground up, partnering with leading academic scientists to translate groundbreaking scientific discoveries into transformative therapies. With a strong commitment to high-impact ventures, the firm is particularly known for its deep involvement in the early stages of company formation, often acting as a founding investor. Newpath Partners manages multiple funds, with its second fund, raised in 2021, amounting to $350 million. This fund continues Newpath’s mission to back companies with high scientific originality and ambitious goals, particularly in areas like regenerative medicine, genomics, and oncology. The firm typically invests in early-stage ventures, providing not only capital but also strategic guidance and access to a network of industry leaders. Dr. Cahill, who also founded the nonprofit Scientists to Stop COVID-19, leads a team that is highly experienced in both science and business, ensuring that the companies they back are well-positioned to make a significant impact in the life sciences arena. Newpath’s approach is characterized by a close collaboration with founders, aligning interests across scientists, investors, and management teams to drive innovation and success.

Newton Biocapital is a Brussels-based venture capital firm with a strong presence in both Europe and Japan, focusing exclusively on the life sciences sector. Established in 2017, the firm’s investment strategy is centered on supporting companies that tackle chronic diseases, with an emphasis on oncology, metabolic diseases, and neurological conditions. Newton Biocapital plays a hands-on role in its portfolio companies, often leading funding rounds and taking board positions to guide scientific and clinical strategies​. The firm manages two funds—Newton Biocapital I (€114M) and Newton Biocapital II, which is currently targeting €150M. NBC I invested in 14 companies across Europe and Japan, including university spin-offs like Epics Therapeutics and ChromaCure in Belgium, and biotech firms like EditForce in Japan. Newton's approach is deeply integrated with the local ecosystems in both regions, leveraging their strong ties to academic institutions, industry experts, and international investors to facilitate cross-border growth and exits​. Newton’s team combines scientific, regulatory, and investment expertise, led by CEO Alain Parthoens. With offices in Brussels and Tokyo, they are uniquely positioned to bridge the innovation pipeline between Europe and Japan, driving impactful advancements in life sciences​.

NewTribe Capital is a Dubai-based venture capital firm primarily investing in early-stage Web3, blockchain, and AI startups. With a portfolio exceeding 200 projects globally, including sectors like DeFi, gaming, infrastructure, and NFTs, NewTribe actively fosters innovation in the digital space. Some notable investments include Cookie3 and KIP, with an average check size around $200,000. The firm focuses on building long-term partnerships, often providing advisory services such as market-making, growth hacking, and smart contract auditing, to ensure the success of its portfolio companies​. Geographically, NewTribe targets the MENA region, but also extends investments into Europe, Asia, and beyond. Its strategy emphasizes infrastructure development that bridges Web2 and Web3, alongside token-based and equity investments. Notably, NewTribe backs projects aligning with Dubai’s Web3 initiatives, offering support through accelerator programs and partnerships. Led by partners such as Dhaval Parikh and Juliet Su, NewTribe’s team combines technical expertise with deep industry connections. For startups seeking funding, NewTribe looks for founders with strong visions in blockchain or AI, particularly those aiming to create large-scale digital infrastructure.

Next 10 Ventures, founded in 2018 by former YouTube executive Ben Grubbs, is a venture firm dedicated to the global creator economy. Headquartered in Los Angeles and Singapore, the firm focuses on early-stage investments and incubation of businesses within the digital content space. With a $50 million fund, Next 10 Ventures supports startups that offer tools and services for content creators, such as GoMeta, which helps design interactive experiences, and SuperBam, a digital rights management firm. The firm’s average investments range from $250,000 to $500,000. Next 10 Ventures specializes in creator-driven businesses in areas like education, entertainment, and entrepreneurial ventures. Their investment strategy targets creators looking for long-term growth, avoiding short-term "money-grab" opportunities. The firm also provides substantial operational support, including crafting business models for creators, many of whom lack formal plans. The team, including hires like Lauren Schnipper, formerly of Facebook, is spread across key creative hubs like Los Angeles and Singapore, with plans to scale in regions with high creator activity. The firm looks for creators who fit into categories such as artists, entrepreneurs, and educators, while prioritizing sustainability and community impact​.

Next Frontier Capital, founded in 2015 and headquartered in Bozeman, Montana, is an early-stage venture capital firm that partners with mission-driven entrepreneurs in the Rocky Mountain region. The firm focuses on investments in B2B technology and deep tech companies at the Seed and Series A stages. They manage four funds, with the latest being Fund IV, and typically invest between $2 to $10 million per round​. Next Frontier Capital emphasizes supporting the underserved Rocky Mountain startup ecosystem. Their portfolio includes companies like Submittable, Bridger Photonics, and Claravine, reflecting their commitment to high-impact technology ventures​​. The firm values diversity, intellectual rigor, and a strong connection to the region, aiming to create long-lasting companies that contribute significantly to their communities​. The team at Next Frontier Capital, led by founders Will Price and Richard Harjes, brings extensive experience from both venture capital and operational roles. They provide hands-on support to their portfolio companies, leveraging their network and expertise to help founders succeed.

Credit Suisse Entrepreneur Capital Ltd., established in 2010, is the venture capital arm of Credit Suisse based in Zurich, Switzerland. The firm focuses on investing in innovative small and medium-sized enterprises (SMEs) and startups across various sectors, including robotics, automation, medtech, and fintech. To date, Credit Suisse Entrepreneur Capital has invested around CHF 130 million in over 50 companies, and recently expanded its fund by an additional CHF 70 million, bringing the total to CHF 200 million. Notable investments from Credit Suisse Entrepreneur Capital include Perspective Robotics (d.b.a. Fotokite), a Zurich-based startup specializing in tethered drones that improve the safety and efficiency of public safety operations, and Ava, a company in the monitoring equipment sector. These investments highlight the firm’s commitment to supporting high-potential technologies and innovative business models. Credit Suisse's venture capital efforts are part of a broader strategy to support Switzerland's entrepreneurial ecosystem, ensuring the country remains a global leader in innovation and business. For more information about their investments and strategic approach, you can visit their official website.

Next47, the global venture capital arm of Siemens, focuses on investing in early and expansion-stage enterprise tech startups. With a presence in Palo Alto, Berlin, Tel Aviv, London, Munich, and Paris, Next47 specializes in sectors like SaaS, AI, and enterprise technology. Their portfolio boasts notable companies such as Verkada, Skydio, and ChargePoint, reflecting their expertise in backing high-potential tech ventures. Next47's investment strategy emphasizes deep engagement with portfolio companies, providing strategic advice, connections, and resources to help them scale. They lead funding rounds with average check sizes varying based on the stage and requirements of the startup. The firm prides itself on a long-term partnership approach, ensuring consistent support through every growth phase. The fund is highly active, with a robust network of 250+ customers across 15 countries, enabling startups to accelerate their go-to-market strategies and secure significant bookings. Founders benefit from Next47's extensive talent network, assisting in making critical hires and developing executive recruiting strategies. Key team members include Lak Ananth, CEO and Managing Partner, and T.J. Rylander, General Partner, both based in Palo Alto. Their combined experience in venture capital and enterprise tech provides invaluable guidance to startups navigating complex growth trajectories. Next47’s global reach and strategic focus make it a vital player in the enterprise tech venture capital landscape, committed to driving innovation and supporting founders in building the next generation of category-leading companies.

NextGen Venture Partners is a unique venture capital firm that leverages a network-driven approach to investing. Founded in 2012 and based in Baltimore, Maryland, the firm collaborates with over 1,800 Venture Partners to support early-stage and growth-stage companies across various industries in the US​. NextGen typically invests between $1 million to $2 million in seed-stage companies and $3 million to $5 million in growth-stage companies that have $10 million+ in revenue. Their network of Venture Partners, consisting of top entrepreneurs and executives, provides startups with valuable connectivity for sales, hiring, and financing introductions, as well as on-demand advice. The firm's leadership team includes Managing Partners Jon Bassett, Ben Bayat, Brett Gibson, and Chris Keller, along with other experienced professionals like Deborah Chu (Principal) and Corinne Smeriglio (Director of Operations)​. This team brings decades of combined experience in investing and building companies.

NFX, founded in 2015 and headquartered in San Francisco, is a venture capital firm that specializes in early-stage investments. The firm is renowned for its focus on network effects, which it believes are crucial for building market-transforming companies. NFX invests in a diverse range of sectors, including AI, biotech, fintech, gaming, enterprise software, marketplaces, and crypto, with a particular focus on Silicon Valley and Israel. Notable investments by NFX include companies like DoorDash, Lyft, Patreon, and Houseparty. The firm has made a total of 577 investments and has seen significant exits such as Similarweb and CircleUp. NFX's unique approach involves deeply understanding and leveraging network effects, which it views as essential for startups to compete effectively in today's market​​. The firm was co-founded by James Currier, Pete Flint, Gigi Levy-Weiss, and Stan Chudnovsky, who bring extensive entrepreneurial and investment experience. NFX supports its portfolio companies through The Guild, an active community of over 200 founders who share KPIs, insights, and access to foster mutual growth and success​. NFX aims to transform how true innovators are funded, providing not just capital but also strategic guidance to help startups build sustainable and disruptive businesses​.

ND Capital, formerly known as NanoDimension, is a venture capital firm established in 2002, headquartered in Woodside, California. The firm focuses on investing in disruptive technologies across the life sciences, physical sciences, and data sciences sectors. Their core belief is that significant breakthroughs will arise from the convergence of these scientific disciplines. The firm is led by founder and CEO Aymeric Sallin, who has been pivotal in steering the company towards successful investments. ND Capital supports early to mid-stage companies, particularly those developing innovative and market-disruptive technologies. Their investment strategy targets companies at the forefront of scientific advancements that hold the potential to create substantial impact. ND Capital's diverse portfolio includes investments in companies like Natron Energy, Tarveda Therapeutics, Selecta Biosciences, and SQZ Biotech. The firm has a strong track record with numerous successful exits, such as the acquisition of Serotiny by Johnson & Johnson and Icosavax's IPO. The team at ND Capital consists of experienced professionals with deep expertise in various scientific and industrial fields. This includes Senior Partner Patrick Aebischer, who has extensive experience in biotechnology and academic leadership, and Partner Eric Moessinger, who focuses on life sciences investments. ND Capital's mission is to back visionary founders and innovative startups that push the boundaries of science and technology, driving forward transformative solutions that address global challenges..

Nimble Ventures, founded in 2012, is a venture capital firm based in San Francisco, California. The firm focuses on early-stage investments, primarily targeting sectors such as technology, healthcare, biotech, fintech, consumer tech, and blockchain. Nimble Ventures invests globally, with notable investments in companies based in the United States and Israel. Prominent companies in their portfolio include Umbra, a developer of SAR micro-satellites for imagery services, and Terradepth, which provides data collection technology for marine tracking systems. Both companies have shown significant growth and innovation within their respective fields. Nimble Ventures typically invests in Seed and Series A stages, supporting startups with high growth potential and innovative solutions. The firm's investment strategy emphasizes identifying and nurturing early-stage companies that have the potential to transform industries through cutting-edge technology and novel approaches. For startups looking to engage with Nimble Ventures, it is important to demonstrate strong technological capabilities and a clear path to market leadership. The firm values innovative solutions that address substantial market needs and have the potential for significant impact. Key team members include John Burbank, a notable investor with a background in managing substantial venture funds, and Nathan Mee, who brings extensive experience in portfolio management and venture capital investments​.

Nina Capital is a specialized venture capital firm based in Barcelona, focusing on early-stage investments in health technology. Founded by Marta Gaia Zanchi, the firm invests across Europe, the United States, Canada, Israel, and Australia. Nina Capital leverages the Biodesign process from Stanford, which emphasizes a need-driven and value-based approach to healthcare innovation. Their investment strategy spans pre-seed to seed stages, with typical investment sizes ranging from €200k to €1.5m​. The firm supports startups that apply advanced data science, engineering innovation, and IT-enabled products to solve healthcare challenges. Notable portfolio companies include QuantHealth, which uses AI to predict patient responses in clinical trials, and Cardiomatics, offering automated ECG interpretation to improve healthcare efficiency​. The core team, led by principals like Anastassiou and Yahel Halamish, combines deep expertise in healthcare, technology, and investment. They are committed to diversity and multidisciplinary collaboration, fostering an inclusive environment that promotes innovative solutions to complex healthcare problems.

Nissay Capital, a venture capital firm based in Tokyo and wholly owned by Nippon Life Insurance Company, has a rich history of investments across various stages and sectors. With over 1,200 unlisted companies and 226 IPOs since its inception in 1991, the firm is a significant player in Japan's venture capital landscape. Notable investments include Heartseed, a biotech company, SkyDisc, and LaFabric. They focus on early to growth-stage businesses, with investments ranging from $4M to $740M. Nissay Capital's strategy emphasizes leveraging the vast network of Nippon Life Insurance to support portfolio companies, providing extensive guidance on management strategies and capital policies. They prefer investing in innovative startups that align with their long-term vision of contributing to society, particularly in technology and healthcare sectors. The firm typically co-invests with other major players like Mitsubishi UFJ Capital and CyberAgent Capital, fostering a collaborative investment environment. Key team members include Eiji Arima, the President and CEO, who plays a pivotal role in steering the firm's strategic direction. Nissay Capital prefers entrepreneurs to approach them through well-researched pitches that clearly articulate the market opportunity and technological innovation. Active and involved, they are seen as a hands-on investor committed to the growth and success of their investees

Noaber is a purpose-driven venture fund based in the Netherlands, with a mission to create meaningful and sustainable healthcare solutions. The firm invests in early-stage ventures that drive impactful innovations in healthcare, focusing on improving health outcomes while reducing costs and increasing both patient and provider satisfaction. Noaber’s investment strategy revolves around the “Quadruple Aim” of healthcare, which seeks to improve the overall health of populations, enhance the patient experience, reduce healthcare costs, and improve the work life of healthcare providers. The fund’s core investment areas include health activation, early screening and diagnostics, chronic disease management, and health system innovation. Examples of Noaber’s portfolio include Alba Health, which uses microbiome science and AI to prevent chronic diseases, and Momo Medical, which supports caregivers in nursing homes through advanced patient monitoring technology. Another noteworthy investment is Habitual, a digital intervention program that helps manage type 2 diabetes by providing scalable, cost-effective patient support. Noaber is heavily involved in the (pre-)seed stage and frequently serves as the first professional investor in companies. Although its primary focus is on ventures in the Benelux region, Germany, Austria, Switzerland, and Scandinavia, Noaber is expanding its reach through strategic partnerships, including plans to enter the U.S. market. In addition to direct investments, Noaber also participates in investment funds that share its vision for driving healthcare innovation. Noaber’s approach is hands-on, fostering close collaborations with entrepreneurs to inspire broader investment in socially impactful healthcare innovations.

Noetic Fund is a Toronto-based venture capital firm launched in 2020, specializing in early-stage investments within the healthcare, psychedelic medicine, and biotech sectors. The fund focuses on emerging therapies and technologies aimed at improving mental health, addressing central nervous system disorders, and offering innovative solutions to global healthcare challenges. Noetic is particularly involved in the burgeoning field of psychedelic-based therapeutics, where they support companies working on treatments for conditions such as depression, PTSD, and substance use disorders. With its first fund, Noetic made around 20 investments, including notable companies like COMPASS Pathways, MindMed, and Cybin, all leaders in the psychedelic medicine space. They’ve continued to expand with the launch of Noetic Fund II, aiming to raise $200 million to further invest in groundbreaking therapies. Their strategy includes a long-term focus on companies developing new drug discoveries, digital health solutions, and medical devices that address unmet needs in mental and physical health. Noetic’s leadership includes seasoned venture capitalists and experts in life sciences, positioning the firm to capitalize on the growing acceptance and scientific validation of psychedelic treatments. They collaborate closely with portfolio companies, leveraging their expertise to foster sustainable growth and innovation.

Nomad Ventures is an early-stage VC firm based in Los Angeles, with a strong focus on high-growth, network-effect businesses. Their sector-agnostic approach includes fintech, consumer tech, vertical SaaS, and marketplaces, backing startups that drive new ways for people to earn money online. With notable investments in companies like Cameo and Wheels, Nomad Ventures has a track record of identifying disruptive, scalable business models. The fund primarily targets pre-seed and seed-stage investments, aiming to partner with founders who exhibit grit and a bold vision for the future. They seek startups with operational intensity and scalable distribution advantages. While geographically anchored in the U.S., particularly cities like Los Angeles, New York, Austin, and Miami, they are open to the growing decentralization of startup ecosystems across the country. Led by Chris Taylor, James Mumma, and Marco McCottry—all experienced operators who played key roles at Uber, Bird, and Opendoor—the team brings hands-on expertise and operational guidance to their portfolio companies. They actively co-invest with top-tier VCs like Andreessen Horowitz, often helping lead rounds with average check sizes ranging from $250K to $1M. Nomad is known for being approachable and looking for founders who build defensible businesses with strong marketplace dynamics. Nomad Ventures has raised over $100M and frequently scouts startups through industry relationships and tech scene connections, with a preference for companies demonstrating early, clear traction.

NOMO Ventures is a venture capital firm specializing in early-stage investments in transformative technology companies. With over $100 million in assets under management, NOMO Ventures has a diverse portfolio that includes prominent companies such as Expensify, Nest, MeUndies, Simulate, Better Mortgage, Ponto, Batch, and Railz​ (HealthTech Alpha)​​ (Unicorn Nest)​. Their investment strategy focuses on early-stage ventures, often co-investing with other notable funds like Global Founders Capital and Pioneer Fund. NOMO Ventures tends to back companies that offer innovative solutions and have the potential for significant market impact. They have made investments in a variety of sectors, including health tech, fintech, and consumer products. NOMO Ventures is based in San Francisco and is actively seeking new investments, typically participating in funding rounds ranging from $2 million to $20 million. They have a track record of investing in startups that achieve high growth and profitability. For instance, recent investments include Great Question, a customer research platform, and Pry Financials, which simplifies startup finances​. Key team members include experienced venture investors who provide hands-on support and strategic guidance to their portfolio companies. NOMO Ventures looks for startups with strong, innovative business models and clear market potential. Startups interested in securing investment from NOMO Ventures should prepare a direct and concise pitch that highlights scalability and strategic fit with NOMO's investment focus​.

NOON Ventures is a Copenhagen-based early-stage venture fund, launched in 2020 by Caspar Høgh and Theis Malmborg. The fund focuses on investing in transformative technologies that tackle environmental and climate challenges. With a hands-on approach, NOON Ventures works closely with its portfolio companies, acting as co-developers to support long-term growth. Their sectors of interest include biotech, clean energy, manufacturing, and sustainability, specifically targeting companies in Northern Europe. The fund typically leads or co-leads investments, with check sizes ranging from €2-5 million. Its notable investments include Spectro Inlets, Enduro Genetics, and Lotus Microsystems, all working on innovative solutions in sustainability and tech. NOON Ventures emphasizes its commitment to limiting the number of investments, ensuring they can deeply engage with each startup across strategy, talent acquisition, and customer growth. NOON Ventures has made sustainability central to its mission, and its investments align with this philosophy, aiming to contribute to the UN's Sustainable Development Goals. Entrepreneurs with proven technology and a passion for environmental impact will find an ideal partner in NOON Ventures, especially if they seek more than just financial backing.

Nordic Alpha Partners (NAP) is a Copenhagen and Munich-based growth equity fund specializing in scaling industrial GreenTech companies. Established in 2017, NAP manages over €275 million across its funds, focusing on helping visionary founders expand their operations from local players to global leaders. The firm’s unique operational approach emphasizes active engagement, with partners working closely with portfolio companies for up to a year before formal investment. This de-risks ventures and supports rapid, capital-efficient growth. NAP's investment strategy is rooted in sustainability, specifically targeting “dark green” companies that contribute to the global green transition. NAP's impact is demonstrated by the abatement of over 1.1 million tonnes of CO2 and the creation of more than 700 jobs across its portfolio. Notable investments include AquaGreen, which revolutionizes biomass pyrolysis for energy and nutrient recovery, and Green Hydrogen Systems, a leader in the green hydrogen revolution. With strong backing from investors like Allianz Global Investors, Novo Holdings, and KfW Capital, NAP has emerged as a leader in the GreenTech space. Their approach is supported by an extensive value-creation toolkit, which guides companies through the complexities of scaling capital-intensive technologies. NAP also fosters future GreenTech leaders by collaborating with academic institutions, including the Technical University of Denmark. Committed to economic sustainability, NAP helps fuel the growth of next-generation companies that drive the global green transformation while ensuring long-term financial success for their investors.

NFT Ventures, established in 2014 and based in Stockholm, is a prominent venture capital firm specializing in fintech investments. The firm has carved out a niche within the Nordic fintech ecosystem, backing startups that are transforming the financial industry through innovative technologies. NFT Ventures focuses on a broad range of fintech verticals, including regtech, insurtech, and more, investing in companies that have significant scalability and growth potential. NFT Ventures is an active investor, often taking board seats to provide strategic guidance and operational support to its portfolio companies. The firm has built a diverse portfolio of around 40 companies, including notable names like Gimi, a financial education app for children, and Lunar, a modern digital bank. Their approach extends beyond mere financial investment; they leverage their extensive network and deep industry expertise to help their portfolio companies succeed. With a strong presence in Northern Europe, NFT Ventures is well-positioned to continue driving fintech innovation across the region.

Nordic Makers, established in 2016, is an early-stage investment firm founded by a group of experienced angel investors from the Nordic region. The firm focuses on seed and early-stage investments, primarily in technology-driven startups across the Nordics and Europe. Their investment philosophy centers on providing founder-friendly terms and leveraging their extensive network to support entrepreneurial growth. Notable investments by Nordic Makers include Labster, a leading provider of virtual science labs; Seaborg Technologies, which is developing sustainable nuclear reactor technology; and NextMind, which creates brain-sensing wearable devices for real-time device control. Other significant investments include Willa Pay, Helix Nano, LetsBuild, Singa, and Climateview​. The firm’s founding partners, such as Klaus Nyengaard, Esben Gadsbøll, and Alexander Aghassipour, bring a wealth of experience from successful ventures like Just Eat, WhiteAway, and Zendesk. They focus on fostering cross-border investments and integrating the Nordic and Baltic startup ecosystems.

NordicNinja VC is a leading venture capital fund with a €200 million second fund targeting climate tech and deep tech startups across Northern Europe, the UK, and the Benelux. Founded in 2019, the firm is a joint venture backed by Japan Bank for International Cooperation (JBIC), Honda, Omron, and European investors like BaltCap and Swedbank. NordicNinja invests between €2.5 to €10 million in Series A and B rounds, supporting founders addressing global challenges in sustainability, digitalization, and innovative tech solutions. The fund’s portfolio includes high-profile companies like Bolt, Veriff, Einride, and Voi, emphasizing sectors such as electric and autonomous mobility, AI, and immersive digital tools. While around half of NordicNinja’s investments are concentrated in mobility and transportation due to their potential for significant carbon reduction, the firm has also backed companies in sectors like healthcare and digital identity verification, leveraging AI and mixed reality to solve pressing societal problems. Led by managing partners Shinichi Nikkuni, Marek Kiisa, Rainer Sternfeld, and Tomosaku Sohara, the team combines deep expertise in engineering, green energy, and international business. This allows NordicNinja to bridge Japanese and European ecosystems, offering founders access to Japanese corporate networks, enhancing market reach, and supporting scalable, impactful innovation. The fund prioritizes founders with ambitious visions and a readiness to lead in creating a sustainable, tech-driven future, making NordicNinja an ideal partner for startups ready to tackle the world's most critical challenges.

Norrsken VC is a prominent European venture capital firm focused on impact investing, founded in 2017 in Sweden. The firm supports startups that address significant global challenges while aiming for substantial financial returns. Norrsken VC specializes in sectors such as climate tech, energy, biotech, AI, and health tech, ensuring each investment aligns with the UN Sustainable Development Goals (SDGs)​​. Norrsken VC's portfolio includes high-impact companies like Northvolt, a battery manufacturer; Einride, which develops electric autonomous transport; and 1KOMMA5°, focused on sustainable energy solutions. These companies exemplify Norrsken's commitment to backing startups that positively impact both people and the planet​. The firm recently closed its second fund at €320 million, surpassing its original target of €250 million, making it the largest early-stage generalist impact fund in Europe. This fund is supported by major institutional investors, including Folksam, AP1, and the European Investment Fund (EIF), and aims to empower "force of nature" founders to create impact unicorns​. Norrsken VC's team comprises experienced venture capitalists and industry experts, including General Partners Niklas Adalberth, Tove Larsson, Agate Freimane, and David Frykman. The team is dedicated to finding visionary founders across Europe who share their passion for creating a better future through innovative solutions​.

North Bridge Venture Partners, founded in 1994 and based in Wellesley, Massachusetts, is a venture capital firm that provides seed-to-growth financing. The firm focuses on several key sectors, including communications and infrastructure, software, materials, healthcare, and digital media. North Bridge Venture Partners supports companies from their initial stages through to becoming market leaders, leveraging a combination of operational experience and strategic guidance​. The firm has made over 479 investments and has achieved 183 exits. Notable portfolio companies include Couchbase, Markforged, and Lyra Therapeutics. North Bridge has a significant presence in the U.S. market, focusing primarily on early-stage and growth-stage companies operating in healthcare and information technology sectors​. North Bridge is led by a team of experienced professionals, including founder and managing partner Edward Anderson and general partners Richard D'Amore and Jeffrey McCarthy. The firm's strategy emphasizes investing in exceptional entrepreneurs whose ideas have the potential to disrupt their respective industries.

North Shore InnoVentures (NSIV) is a non-profit incubator focused on accelerating the growth of early-stage life sciences and cleantech startups. Based in Beverly, Massachusetts, NSIV provides crucial support through shared lab space, resources, and business mentoring. With two main incubator facilities—the Biotech InnoVenture Center and the Cleantech InnoVenture Center—NSIV has supported over 70 companies since its founding in 2009. Collectively, these startups have raised over $1 billion in funding and created more than 500 jobs​. NSIV specializes in helping companies in the life sciences, healthcare, medical devices, and clean energy sectors. Its investment strategy focuses on early and seed-stag. Led by CEO Chris Ilsley, NSIV emphasizes creating a collaborative environment that nurtures innovation. Companies at NSIV benefit from mentoring programs, expert advisory panels, and connections with potential investors, making it an ideal launching pad for early-stage ventures​.

The North West Fund is a £155 million investment fund aimed at supporting small and medium-sized enterprises (SMEs) in the North West of England. Managed by North West Business Finance Limited, an independent private sector company, the fund was established to address gaps in lending, venture capital, and private equity markets. The fund has been fully invested, supporting over 443 businesses and creating more than 6,300 jobs in the region. The fund comprises several sub-funds, each managed by different fund managers, providing a range of financial support from equity investments to loans. These sub-funds include The North West Fund for Venture Capital, Mezzanine, Loans Plus, Micro Loans, Energy and Environmental, Biomedical, and Digital and Creative. These funds have been instrumental in facilitating the growth and expansion of innovative businesses across various sectors. The North West Fund has a strong team of experienced professionals, including Cliff Maylor (Chief Executive Officer), Neil Morrey (Chief Operating Officer), and Mike Kenyon (Chief Financial Officer). The fund's governance is supported by an independent Board and an Investment Advisory Panel with expertise in private equity, venture capital, and the targeted sectors.

North West Quadrant (NWQ) Ventures, based in Menlo Park, California, is a venture capital firm that specializes in early-stage investments in disruptive technologies. Founded in 2010, NWQ Ventures primarily focuses on companies that are pushing the boundaries of innovation, particularly in sectors like digital media, fintech, and real estate services. NWQ Ventures supports startups that aim to achieve something unprecedented, providing them not just with capital, but also with strategic guidance on patents, manufacturing, market entry, and venture debt financing. The firm has a global outlook and takes a hands-on approach with its portfolio companies, helping them scale through mid-stage growth financing and by leveraging a strong network of co-investors and partners. NWQ's portfolio includes diverse investments like MoonPay and Typewise, showcasing its commitment to high-growth industries. The firm's strategy centers around helping these early-stage companies reach significant milestones by offering both financial and strategic resources. NWQ Ventures operates with a forward-thinking investment thesis, targeting companies that have the potential to reshape their respective industries and create lasting impact. The firm plays a crucial role in bringing new technological advancements to market, ensuring that the startups it backs are well-positioned for success​.

Northern Gritstone is a venture capital firm established in 2020, focused on commercializing cutting-edge science and technology emerging from the North of England. With headquarters in Manchester and strong ties to the Universities of Manchester, Leeds, and Sheffield, Northern Gritstone primarily invests in early-stage companies that originate from these institutions or are based in the region. The firm manages a substantial fund, recently closing at £312 million, to support startups in sectors like deep technology, life sciences, healthcare, and advanced materials. Northern Gritstone's investment strategy is driven by a philosophy of "profit with purpose," aiming to generate financial returns while also contributing to the economic development of the North of England. Northern Gritstone has already made significant investments in companies such as Optalysys, a photonic chip firm, and AssetCool, which develops advanced coatings for industrial applications. The firm is committed to fostering a tech ecosystem in the region, aspiring to create a "Silicon Valley of the North" by backing visionary companies with strong intellectual property and high growth potential.

NPV Ventures is a venture capital firm that focuses on investing in early-stage technology companies, particularly in fintech, consumer tech, and enterprise software. The firm seeks to partner with founders who are building transformative solutions that have the potential to disrupt their industries. NPV Ventures is known for its hands-on approach, working closely with its portfolio companies to provide not just capital but also strategic guidance, operational expertise, and access to a vast network of industry leaders and investors. Founded by a group of seasoned entrepreneurs and investors, NPV Ventures aims to be the first institutional capital into a startup, often investing at the seed and pre-seed stages. The firm takes pride in backing high-growth potential companies and helping them scale by leveraging their deep industry insights and connections. Their portfolio includes innovative startups that are making significant strides in their respective markets. NPV Ventures typically writes initial checks in the range of $250,000 to $1 million and continues to support its companies through follow-on investments. The firm is particularly interested in startups that are solving complex problems with scalable business models, and they prefer to work with founders who demonstrate strong vision, leadership, and execution capabilities. With a focus on both U.S. and international markets, NPV Ventures continues to play a significant role in shaping the future of the tech landscape by backing visionary entrepreneurs and game-changing companies.

Northstar Ventures is a UK-based venture capital firm focused on early-stage investments that create a positive social or environmental impact. With a portfolio that spans tech innovation and social enterprises, the firm emphasizes sectors like climate tech, biotech, and healthy aging. Their notable investments include Newcells Biotech, which develops in vitro organ models for drug testing, and NunaBio, a leader in DNA synthesis technology crucial for personalized medicine and data storage solutions​. Geographically, Northstar Ventures primarily focuses on startups in the North East of England but also supports businesses across the UK. They invest through funds such as the North East Innovation Fund and the Northstar EIS Growth Fund, with typical early-stage investments ranging from £300,000 to £1 million​. Their hands-on approach includes extensive support for founders, particularly in sectors that align with sustainability goals, like Low Carbon Materials, which develops environmentally friendly construction materials. Northstar also backs social impact ventures, such as Coping with Cancer North East, reflecting their commitment to community well-being alongside technological innovation.

Norwest Venture Partners (NVP), headquartered in Menlo Park, California, is a prominent venture capital and growth equity investment firm managing over $15.5 billion in capital. Founded in 1961, Norwest has invested in more than 700 companies across various sectors, including enterprise, consumer, and healthcare. Some of their notable investments include companies like Spotify, Adaptive Insights, Udemy, Talkspace, Opendoor, Kendra Scott, and Health Catalyst. These investments highlight Norwest's diversified approach, backing high-impact companies at various stages of growth from early to late-stage. Norwest recently announced the closing of its seventeenth fund, NVP 17, raising $3 billion to continue supporting visionary entrepreneurs. The firm operates globally with offices in Menlo Park, San Francisco, Mumbai, and Tel Aviv, focusing on North America, India, and Israel​. With a strong commitment to their portfolio companies, Norwest offers extensive support through their experienced investment and portfolio services teams, helping businesses navigate growth and scale effectively. This hands-on approach has contributed to their track record of successful exits and sustained growth in their portfolio companies​.

Notation Capital, established in 2015 by Nicholas Chirls and Alex Lines, is a pioneering pre-seed venture capital firm based in Brooklyn, New York. Specializing in early-stage investments, Notation Capital supports technical teams at the inception of their business journeys, often at the idea stage. Notation's notable investments include Spruce, Livepeer, Bison Trails, and Parsec, showcasing their focus on hard tech, infrastructure, and product-centric startups. The fund is heavily focused on the New York City area but does not limit itself geographically if the opportunity aligns well with their investment philosophy. They typically lead the first round of financing with investment sizes ranging from $250K to $750K. Their strategy emphasizes deep involvement from day one, providing not just capital but also substantial operational support, leveraging their extensive network of advisors, founders, and LPs to accelerate growth and product development. Key team members include Nicholas Chirls, who brings expertise in product development and growth strategies from his previous role at betaworks, and Alex Lines, a seasoned software engineer with a decade of experience in building scalable products. Startups looking to engage with Notation Capital should demonstrate a strong technical foundation and a compelling vision for disruptive innovation. They prefer founders who are deeply product-focused and exhibit a strong determination to execute their vision.

New Venture Fund (Norwest Venture Partners) is a leading venture capital and growth equity investment firm with a diversified investment strategy. It focuses on early- to late-stage investments across various sectors, including consumer, enterprise, and healthcare. Norwest has a robust global presence with offices in North America, India, and Israel, enabling it to identify and support innovative companies worldwide. Notable investments by Norwest include companies like Dave, Gong, Swiggy, Udemy, Vuori, and Ritual. These investments demonstrate the firm's commitment to backing visionary leaders and transformative businesses. Norwest’s investment strategy includes providing not only capital but also strategic guidance and operational support to help portfolio companies scale and achieve significant growth. The firm has recently launched its $3 billion fund, NVP XVI, to continue empowering high-impact businesses. In recent years, Norwest has expanded its focus within the healthcare sector to include biotechnology, building on its successes in medical devices, diagnostics, and healthcare services. Norwest's notable exits include companies such as Opendoor, Talkspace, Udemy, Aporeto, CyberX, and Shape Security, among others. The firm is also committed to environmental, social, and governance (ESG) principles, investing in companies that prioritize sustainability and social impact​.

Novo Holdings is a premier life sciences investment firm based in Copenhagen, Denmark, with additional offices in Boston, San Francisco, London, and Singapore. The firm is wholly owned by the Novo Nordisk Foundation and manages an extensive portfolio aimed at generating long-term returns while advancing health and sustainability. Novo Holdings focuses on investments across biotechnology, medical technology, and digital health sectors, supporting companies at various stages, from early development to commercial phases. In 2023, the firm deployed DKK 3.6 billion, including significant investments in 4D Molecular, Alentis Therapeutics, and Lexeo Therapeutics. The firm's strategy emphasizes innovation in patient care and strong financial returns. Notably, Novo Holdings operates with an evergreen fund structure, allowing a long-term perspective on its investments. The firm actively engages with portfolio companies, often taking board positions to leverage its vast network and expertise. The investment team, led by Managing Partner Scott Beardsley, comprises professionals across major life science hubs. Key team members include Amit Kakar, Head of Novo Holdings Asia, and Anna Fan, Senior Partner in the Life Sciences Operating Committee. For startups seeking investment, Novo Holdings values groundbreaking science and robust clinical data, favoring companies with late preclinical or clinical stage compounds in biotech, and commercial stage entities in medtech and digital health

NP-Hard Ventures is an early-stage venture capital fund based in Amsterdam, Netherlands, focused on investing in product-obsessed founders. The firm targets pre-seed and seed stage startups in Europe and the US, particularly those building infrastructure, tools, and decentralized platforms that simplify and enhance productivity. Founded in 2021 by Anke Huiskes, Micha Hernandez van Leuffen, and Paul Veugen, NP-Hard Ventures has raised €12 million in its inaugural fund, exceeding their initial target of €10 million. The fund plans to invest average checks of €250,000 into around 20 startups, reserving 25% of the fund for follow-on investments. Their portfolio includes innovative companies like Tldraw, an open-source drawing tool for software design, and Emidat, a platform aimed at reducing emissions in the construction industry. The firm is particularly interested in software startups with technical founders who are developing enterprise solutions​. NP-Hard Ventures is distinguished by its operational experience, with the founders having collectively invested in over 50 early-stage companies and 15 funds across Europe and the US. The team aims to bring a sense of urgency and competitive edge from their experiences in the San Francisco tech scene to the European startup ecosystem​.

Nucleus Capital, founded in 2020 and based in Berlin, Germany, is a venture capital firm dedicated to supporting early-stage, purpose-driven entrepreneurs tackling systemic challenges to planetary health. They focus on three main sectors: programmable biology, food technology, and green industrials. Notable investments by Nucleus Capital include Yuri, a space biotech company; Planet A Foods, which develops biotech-derived food ingredients; and Hier Foods, a digital platform for food distribution. Other key investments encompass innovative startups like Farmless, which transforms renewable energy into food, and Brineworks, which focuses on ocean-based CO2 removal through electrochemistry​. Nucleus Capital typically invests in pre-seed and seed stages with check sizes ranging from €150k to €1 million. They aim to partner with mission-driven teams possessing deep domain expertise and creative solutions to global environmental challenges​​. The firm is led by co-founders Maximilian Schwarz and Isabella Fandrych, who bring significant expertise and a strong commitment to fostering entrepreneurial innovation for planetary health​.

Nutreco is a global leader in animal nutrition and aquafeed, committed to sustainably feeding the growing global population. Headquartered in the Netherlands, Nutreco operates through two primary business lines: Skretting, which focuses on aquaculture, and Trouw Nutrition, which serves the livestock industry. The company’s overarching mission, known as "Feeding the Future," is to drive sustainability across the entire food production chain. Nutreco's strategy is centered around three main areas: supporting sustainable production through technology, advancing nutrition and animal health, and sourcing future protein ingredients. The company is heavily invested in developing sustainable alternatives to traditional feed ingredients, including the use of insect protein and other novel sources. This approach aims to reduce the environmental footprint of animal farming, which is crucial as feed ingredient production currently accounts for a significant portion of greenhouse gas emissions in the livestock industry. Innovation is a key pillar of Nutreco's operations, primarily driven by their NuFrontiers team, which focuses on breakthrough technologies that can transform the protein value chain. Nutreco has also been expanding its production capabilities in growth markets like Asia and Latin America, as well as optimizing its operations to increase agility and reduce costs. The company’s investments are aimed at not just expanding its market presence but also ensuring that its products and practices are aligned with global sustainability goals, making it a crucial player in the future of food production​.

NXTP Ventures, headquartered in Buenos Aires, is a leading venture capital firm in Latin America, focusing on early-stage tech startups. Their portfolio includes high-growth companies like Auth0, Nuvemshop, and Satellogic. With over 130 investments and numerous successful exits, NXTP is known for supporting innovative ventures in SaaS, logistics, and fintech sectors. They typically invest in Seed and Series A rounds, writing checks between $500k and $2 million. NXTP's strategy involves deep engagement with their portfolio companies, providing not just capital but also operational support, strategic guidance, and access to an extensive network of industry specialists and mentors. This approach has helped many of their investments achieve significant growth and market presence​ . The firm’s key team members, such as co-founder Ariel Arrieta, bring a wealth of experience in both investing and operating within the tech ecosystem. NXTP's investments are spread across Latin America, with a strong presence in Brazil, Argentina, Mexico, Chile, and Colombia.

Oak Investment Partners is a leading multi-stage venture capital firm that focuses on high-growth opportunities across several sectors, including information technology, financial services technology, healthcare, and clean energy. Founded in 1978, Oak has invested over $9 billion in more than 525 companies worldwide. The firm is known for its hands-on approach, offering comprehensive support and strategic assistance through its extensive network of industry experts. Oak's portfolio includes notable companies such as Castlight Health, Zayo Group, Kayak, Benefitfocus, and Protean Electric, among others. Their investment strategy spans early to late-stage investments, including growth equity and PIPE (private investment in public equity) investments. Oak Investment Partners has built a reputation for its ability to identify transformative opportunities and support them through long-term, steady guidance​. The firm is headquartered in Norwalk, Connecticut, with additional offices in California. The team includes experienced professionals like Managing Partners Bandel Carano, Ed Glassmeyer, Fred Harman, and Ann Lamont, who bring deep domain expertise and a consistent investment philosophy to the table​.

O'Reilly AlphaTech Ventures is an early-stage venture capital firm founded by Tim O’Reilly, Mark Jacobsen, and Bryce Roberts. Established in 2005, OATV focuses on institutional seed investing and supporting founders who are customer-centric and revenue-focused. The firm has pioneered investment strategies aimed at helping startups grow sustainably. OATV’s portfolio includes companies like Figma, Bitly, and Planet Labs, showcasing their commitment to backing innovative tech ventures. The firm provides not just capital but also mentorship and strategic guidance, leveraging the founders’ extensive entrepreneurial experience.

Obvious Ventures, founded in 2014 and based in San Francisco, is a venture capital firm focused on early and growth-stage investments. The firm emphasizes investments that align with their "world positive" approach, targeting sectors like planetary health, human health, and economic health. This mission-driven investment strategy seeks to support companies that create a positive impact on the world while generating significant financial returns. Notable investments by Obvious Ventures include Beyond Meat, Medable, and Dexterity. Beyond Meat, known for its plant-based meat products, went public in 2019, marking a significant milestone for the firm. Medable provides a cloud-based platform for decentralized clinical trials, while Dexterity develops AI-driven robotic systems for managing warehouses. Obvious Ventures has a diverse portfolio of over 130 companies, with successful exits including Recursion Pharmaceuticals, Lilium, and Proterra. The firm's portfolio spans various industries such as AI, biotech, fintech, and sustainable consumer goods. The team at Obvious Ventures includes co-founders Ev Williams, James Joaquin, and Vishal Vasishth, who bring extensive experience in entrepreneurship and venture capital. They are committed to supporting visionary founders who are building transformative companies.

OCA Ventures, based in Chicago, is an early-stage venture capital firm that has been investing since 1999. The firm primarily targets technology, financial services, education, and healthcare technology sectors. Their investment strategy focuses on Seed, Series A, and Series B rounds, with typical initial investments ranging from $1 to $4 million. They often lead the rounds in which they participate. Notable companies in their portfolio include SpotHero, a parking app; Base CRM, a cloud-based customer relationship management software; Pangea, an online money transfer service; and Cleversafe, a cloud-based data storage system. Other significant investments include dv01, LogicGate, and Placer.ai. OCA Ventures is also known for its OCA EDGE program, which invests $50,000 to $200,000 in seed rounds of about $1.5 million or less. This program is designed to support early-stage startups with potential for dramatic growth. The firm has a strong track record of successful exits, including the sale of Cleversafe to IBM and the IPO of Marqeta. Led by CEO Jim Dugan and co-founders John Dugan and Peter Ianello, OCA Ventures leverages a robust network of strategic relationships to support their portfolio companies and drive their growth.

Octopus Ventures, established in 2007 and headquartered in London, is a major venture capital firm in Europe with over £1.2 billion in assets under management. The firm invests in a diverse range of sectors, including B2B software, health tech, fintech, deep tech, consumer, climate, and bio. Their notable investments include well-known companies such as SwiftKey, ManyPets (formerly known as Bought By Many), Zoopla, LoveFilm, and Graze. Octopus Ventures focuses on supporting startups from pre-seed through to Series A and beyond, providing both funding and hands-on support to help companies scale. The firm is committed to backing founders with purpose-driven missions, emphasizing positive impact on people, communities, and the environment. Octopus Ventures employs a strategy that prioritizes long-term relationships with founders and deep sector expertise. They are particularly focused on disruptive technologies and innovative solutions that address significant global challenges. Recent investments reflect their commitment to sustainability and tech innovation, including companies like Token in fintech, Elliptic in blockchain analytics, and Minimum in climate tech. Led by a team of experienced investors and industry experts, Octopus Ventures ensures their portfolio companies receive the strategic guidance and operational support necessary for growth. The firm continues to expand its influence globally, aiming to foster innovation and drive positive change in the venture capital landscape.

OCV Partners is a Los Angeles-based venture capital firm, established with a mission to invest in companies that demonstrate significant growth potential, primarily in the technology and healthcare sectors. Their investment strategy is focused on mid- to late-stage companies, often in fields such as SaaS, fintech, biotech, and digital health. With a portfolio that includes innovative firms like Jukin Media, Scopely, and TaskUs, OCV Partners has positioned itself as a hands-on investor, providing both capital and operational support to help scale high-growth companies​. The firm prides itself on its diverse expertise, backing founders through every phase of their business journey. The OCV team brings decades of experience in building and scaling companies across various industries, from software and financial services to healthcare and media. They partner with startups not just to provide financial backing, but also to offer operational insight, helping businesses navigate the complexities of scaling. OCV Partners is well-known for its long-term mindset, focusing on building sustainable value through innovation and strong partnerships. The firm typically invests in companies at the seed to Series B stages, though they remain flexible and open to later-stage opportunities when appropriate.

Offline Ventures, founded in 2020 and based in Mill Valley, California, is a venture capital firm focused on investing in early-stage startups across diverse sectors such as fintech, healthcare, and consumer technology. The firm is led by co-founders David Morin, Nate Bosshard, Brittany Morin, and James Higa, who bring extensive experience from various successful ventures. Notable investments by Offline Ventures include companies like Sunnyside, which focuses on application software; Kismet, a healthcare services company; and Clarasight, a business productivity software firm. They have a total of 48 investments and have seen several successful exits, including Diagram and Artifact. Offline Ventures is known for supporting startups that innovate at the intersection of technology and culture. They emphasize backing founders who are committed to building impactful and sustainable businesses. The firm also operates a venture studio to help incubate and develop new ideas into successful companies.

Okapi Venture Capital, established in 2005 and based in Newport Beach, California, focuses on seed and early-stage investments in the information technology and life sciences sectors. The firm has made 83 investments and has 18 notable exits, including companies like Welltok, Qualaroo, and CrowdStrike. Their portfolio includes a diverse range of companies such as Occuspace, which provides smart building solutions, Trellis Research in legal tech, and Daasity, which offers eCommerce analytics solutions. Other significant investments include Babylist, an online discovery platform for baby products, and ChromaCode, which uses data science for advanced molecular diagnostics. Okapi's investment strategy emphasizes supporting innovative startups with high growth potential, often leading seed and Series A rounds. The team is led by co-founders Marc Averitt and Sharon Stevenson, alongside partners like Jeff Bocan and John Waller, who bring extensive experience in venture capital and technology management. The firm is particularly active in the US market and collaborates with co-investors such as SaaS Ventures, Mucker Capital, and Stage Venture Partners, to foster the growth and success of its portfolio companies.

Olive Tree Capital is a dynamic venture capital firm headquartered in Boston, Massachusetts, focusing on early-stage investments across various tech-driven sectors. Notable investments include Uber, Postmates, and Lark, illustrating their keen eye for potential high-growth startups. With a strong portfolio in Artificial Intelligence, Machine Learning, Health & Wellness, and Big Data & Analytics, Olive Tree Capital seeks to back transformative companies from pre-seed through Series A stages. Their investment strategy is characterized by flexibility and an evergreen capital structure, allowing them to lead rounds and provide significant follow-on funding without the constraints of traditional fund timelines. This approach facilitates a long-term partnership with startups, aiming for substantial growth and successful exits, as demonstrated by their involvement in high-profile mergers and acquisitions like those of Bueno Finance and 10 Minute Squad. The firm’s geographic focus extends primarily across the United States, with a pronounced presence in the Boston area. Key team members, including Managing Partners Nichola Eliovits and Yamen Al-Hajjar, bring extensive experience in technology and biotechnology, reinforcing the firm's industry expertise and strategic guidance. Olive Tree Capital’s investment process emphasizes rigorous due diligence and a collaborative approach with co-investors like Y Combinator and Soma Capital. Startups seeking to engage with Olive Tree Capital are encouraged to present a compelling vision for innovation and market disruption, aligning with the firm’s commitment to transformative impact and sustainable growth​.

Omega Venture Partners, based in Palo Alto, California, is a leading venture capital firm specializing in AI, machine learning, data, and automation. Their investment strategy is centered around identifying high-growth companies at the early-growth stage, particularly those that leverage AI to solve significant business challenges. Omega's portfolio includes companies like ZenBusiness, DataRobot, Verbit, and Elemental Machines, showcasing their focus on businesses that deliver transformative solutions across industries. Omega typically invests at the inflection point of a company’s growth, providing funding between $1M and $10M per round. Their thematic approach ensures they target companies with large-scale potential, helping them scale rapidly through access to a proprietary network of Fortune 500 executives and strategic partners. This network enables Omega to deliver high-value introductions, mentorship, and go-to-market strategies, adding significant value beyond capital. The firm's leadership, including Managing Partner Gaurav Tewari, has a deep track record in tech investing. Omega's expertise in guiding AI-driven companies makes them a preferred partner for entrepreneurs seeking to revolutionize industries like healthcare, fintech, and digital transformation.

OMERS Ventures, the venture capital arm of the Ontario Municipal Employees' Retirement System, focuses on investing in Series A to C companies across North America. Founded in 2011, the firm has backed several high-profile tech companies like Shopify and Wave. Their investment strategy centers on transformative technology sectors, including fintech, healthtech, proptech, and workplace technology. Typical initial investments range from $5 million to $25 million. OMERS Ventures has decided to withdraw from the European market to concentrate its efforts on North America. This strategic shift follows a challenging market environment in Europe and aims to leverage North America's relative economic stability. As part of this transition, the firm plans to open a new office in New York while maintaining its presence in Toronto and San Francisco. The leadership team includes Michael Yang, who emphasizes the importance of building strong relationships with founders and has a background in investing in emerging areas such as healthtech and IoT. For startups looking to engage with OMERS Ventures, demonstrating a deep understanding of the market and a clear vision for growth is essential. The firm values transparency and strong founder-investor relationships, aiming to support companies through various market challenges and opportunities.